Pinnacle Wealth Planning Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$404K Sell
533
-7
-1% -$5.29K 0.04% 276
2026
Q2
$337K Sell
540
-20
-4% -$13.6K 0.03% 334
2026
Q1
$433K Buy
560
+94
+20% +$72K 0.04% 244
2025
Q4
$360K Buy
466
+5
+1% +$3.4K 0.04% 278
2025
Q3
$259K Sell
461
-14
-3% -$7.92K 0.03% 369
2025
Q2
$249K Sell
475
-14
-3% -$7.81K 0.03% 350
2025
Q1
$310K Buy
489
+14
+3% +$9.6K 0.05% 252
2024
Q4
$338K Sell
475
-137
-22% -$115K 0.05% 226
2024
Q3
$643K Hold
612
– – 0.09% 150
2024
Q2
$643K Buy
612
+1
+0.2% +$969 0.09% 139
2024
Q1
$588K Hold
611
– – 0.09% 155
2023
Q4
$537K Sell
611
-2
-0.3% -$1.65K 0.08% 166
2023
Q3
$504K Sell
613
-3
-0.5% -$2.36K 0.08% 160
2023
Q2
$443K Sell
616
-9
-1% -$6.94K 0.07% 187
2023
Q1
$514K Buy
625
+2
+0.3% +$1.51K 0.09% 171
2022
Q4
$449K Buy
623
+12
+2% +$8.85K 0.08% 186
2022
Q3
$421K Buy
611
+30
+5% +$18.9K 0.08% 171
2022
Q2
$343K Sell
581
-13
-2% -$8.45K 0.06% 215
2022
Q1
$415K Buy
594
+165
+38% +$104K 0.08% 199
2021
Q4
$271K Buy
429
+17
+4% +$10.5K 0.05% 281
2021
Q3
$249K Buy
412
+16
+4% +$9.9K 0.06% 279
2021
Q2
$221K Buy
+396
New +$201K 0.05% 298
2021
Q1
– Sell
-270
Closed -$130K – 1586
2020
Q4
$130K Buy
+270
New +$146K 0.03% 383

Other funds holding REGN

Pinnacle Wealth Planning Services's REGN Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2026, selling an estimated $5.29K and leaving 533 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #276.

Pinnacle Wealth Planning Services first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $643K in Q3 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Pinnacle Wealth Planning Services held 533 shares of Regeneron Pharmaceuticals worth $404K as of Q3 2026.
  • Pinnacle Wealth Planning Services sold 7 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $5.29K.
  • Regeneron Pharmaceuticals made up 0.04% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #276 holding.
  • Pinnacle Wealth Planning Services first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Pinnacle Wealth Planning Services's Regeneron Pharmaceuticals position peaked at $643K in Q3 2024.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.